by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Naseem A. Jaffrani, M.D. Warning Letter Details

Warning Letter

Naseem A. Jaffrani, M.D.

Naseem A. Jaffrani, M.D., 3311 Prescott Road, Suite 310 Alexandria , LA 71301 United States

Issue DateMay 04, 2026

FEI NumberN/A

Violations1

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Clinical Investigator

Naseem A. Jaffrani, M.D. FDA Warning Letter, May 4, 2026